Ausgabe 3/2019
Inhalt (10 Artikel)
The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
Robert Hermann, Mats O. Karlsson, Ana M. Novakovic, Nadia Terranova, Markus Fluck, Alain Munafo
Therapeutic Drug Monitoring of Oral Anti-Hormonal Drugs in Oncology
Stefanie L. Groenland, Merel van Nuland, Remy B. Verheijen, Jan H. M. Schellens, Jos H. Beijnen, Alwin D. R. Huitema, Neeltje Steeghs
Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge Gaps
Ruben van der Galiën, Rob ter Heine, Rick Greupink, Stein J. Schalkwijk, Antonius E. van Herwaarden, Angela Colbers, David M. Burger
Effects of Postponing Treatment in the Second Year of Cladribine Administration: Clinical Trial Simulation Analysis of Absolute Lymphocyte Counts and Relapse Rate in Patients with Relapsing-Remitting Multiple Sclerosis
Nadia Terranova, Christine Hicking, Fernando Dangond, Alain Munafo
Population Pharmacokinetic Modeling of Gemtuzumab Ozogamicin in Adult Patients with Acute Myeloid Leukemia
Jennifer Hibma, Beverly Knight
Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy Subjects
Anne Gardin, Mike Ufer, Eric Legangneux, Gianluca Rossato, Yi Jin, Zhenzhong Su, Parasar Pal, Wenkui Li, Kasra Shakeri-Nejad
Population-Pharmacokinetic and Covariate Analysis of Lurbinectedin (PM01183), a New RNA Polymerase II Inhibitor, in Pooled Phase I/II Trials in Patients with Cancer
Carlos Fernandez-Teruel, Ignacio Gonzalez, Iñaki F. Trocóniz, Rubin Lubomirov, Arturo Soto, Salvador Fudio
Population Pharmacokinetics of the Interleukin-23 Inhibitor Risankizumab in Subjects with Psoriasis and Crohn’s Disease: Analyses of Phase I and II Trials
Ahmed A. Suleiman, Amit Khatri, Mukul Minocha, Ahmed A. Othman
Monitoring of Tobramycin Exposure: What is the Best Estimation Method and Sampling Time for Clinical Practice?
Yanhua Gao, Stefanie Hennig, Michael Barras
Correction to: The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
Robert Hermann, Mats O. Karlsson, Ana M. Novakovic, Nadia Terranova, Markus Fluck, Alain Munafo